CSF-1 and TPA stimulate independent pathways leading to lysosomal degradation or regulated intramembrane proteolysis of the CSF-1 receptor

FEBS Lett. 2007 Nov 27;581(28):5377-81. doi: 10.1016/j.febslet.2007.10.031. Epub 2007 Oct 29.

Abstract

The CSF-1 receptor is a protein-tyrosine kinase that has been shown to undergo regulated intramembrane proteolysis, or RIPping. Here, we have compared receptor downregulation and RIPping in response to CSF-1 and TPA. Our studies show that CSF-1 is a relatively poor inducer of RIPping and that CSF-1-induced receptor downregulation is largely independent of RIPping. TPA is a strong inducer of RIPping and TPA-induced receptor downregulation is mediated by RIPping. We further found that RIPping is dependent on TACE or a TACE-like protease, that CSF-1 and TPA use independent pathways to initiate RIPping, and that the intracellular domain is targeted for degradation through ubiquitination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM Proteins / antagonists & inhibitors
  • ADAM Proteins / metabolism
  • ADAM17 Protein
  • Animals
  • Cell Line
  • Down-Regulation / drug effects
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Intracellular Membranes / drug effects*
  • Intracellular Membranes / metabolism*
  • Lysosomes / drug effects
  • Lysosomes / metabolism*
  • Macrophage Colony-Stimulating Factor / pharmacology*
  • Mice
  • Phorbol Esters / pharmacology*
  • Receptor, Macrophage Colony-Stimulating Factor / metabolism*
  • Signal Transduction / drug effects*
  • Time Factors
  • Ubiquitination

Substances

  • Enzyme Inhibitors
  • Phorbol Esters
  • phorbol 12,13,20-triacetate
  • Macrophage Colony-Stimulating Factor
  • Receptor, Macrophage Colony-Stimulating Factor
  • ADAM Proteins
  • ADAM17 Protein
  • ADAM17 protein, human
  • Adam17 protein, mouse